Advertisement
Journal Home
Search for

Volume 205, Issue 1, Pages 290-295 (July 2009)


View previous. 49 of 56 View next.

Synergistic role of inflammation and insulin resistance as coronary artery disease risk factors in African Americans and Caucasians

Erdembileg Anuurada, Russell P. Tracyc, Thomas A. Pearsond, Kyoungmi Kime, Lars BerglundabCorresponding Author Informationemail address

Received 3 September 2008; received in revised form 31 October 2008; accepted 23 November 2008. published online 12 January 2009.

Abstract 

The separate roles of inflammation and insulin resistance (IR) in the pathogenesis of cardiovascular disease (CVD) are well recognized. We investigated whether presence of inflammation would modify coronary artery disease (CAD) risk prediction in subjects with or without IR. Insulin, glucose, CRP and fibrinogen levels were determined in 317 Caucasians and 222 African Americans undergoing diagnostic coronary angiography. Extent of CAD was defined by a composite score (0–75). The overall prevalence of IR (HOMA-IR3.0) in Caucasians and African Americans was 32.5% and 22.9%, respectively (P<0.05). The degree of CAD (composite score) was higher in subjects with IR (20.7 vs. 14.5, P=0.014 and 20.1 vs. 13.1, P=0.031 for Caucasians and African Americans, respectively), and in a multiple regression model IR was an independent predictor for CAD in both groups. In both ethnic groups, subjects with a combination of IR and high CRP (≥3mg/l) had significantly higher composite score compared to those with no IR and low CRP (<3mg/l) (21.2 vs. 13.9, P<0.05 and 20.9 vs. 10.2, P<0.05 for Caucasians and African Americans, respectively). Similarly, the composite score was significantly higher in subjects with IR and high fibrinogen (≥340mg/dl) compared to those with no IR and low fibrinogen. In conclusion, elevated levels of inflammatory markers were positively associated with IR. Further, a combination of IR and inflammation resulted in a higher degree of CAD in both Caucasians and African Americans. The results suggest that inflammation may potentiate the cardiovascular risk factor role of IR.

a Department of Medicine, University of California, Davis, CA, United States

b The VA Northern California Health Care System, United States

c Department of Pathology, University of Vermont, United States

d Department of Family and Community Medicine, University of Rochester, Rochester, NY, United States

e Department of Public Health Sciences, University of California, Davis, CA, United States

Corresponding Author InformationCorresponding author at: Department of Medicine, University of California, Davis, UCD Medical Center, CTSC, 2921 Stockton Blvd, Suite 1400, Sacramento, CA 95817, United States. Tel.: +1 916 703 9120; fax: +1 916 703 9124.

PII: S0021-9150(08)00838-1

doi:10.1016/j.atherosclerosis.2008.11.028


View previous. 49 of 56 View next.

Advertisement